Salvage treatment for patients with acute myelogenous leukemia treated after intensive induction therapy by daunorubicin.

被引：0
|
作者：
Dobashi, N
Usui, N
Asai, O
Yano, S
Uno, S
Watanabe, H
Katori, M
Yahagi, Y
Nagamine, M
Saito, T
Yamaguchi, Y
Kasama, K
Tajima, N
Yamazaki, H
Kobayashi, T
Kuraishi, Y
机构：
[1] Jikei Univ Hosp, Dept Hematol & Oncol, Tokyo, Japan
[2] Jikei Univ, Sch Med, Dept Internal Med 3, Tokyo, Japan
来源：
BLOOD | 1998年 / 92卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3897
引用
收藏
页码：209B / 209B
页数：1
相关论文
共 50 条
  • [1] Outcome of patients with acute myelogenous leukemia after second salvage therapy
    Giles, F
    O'Brien, S
    Cortes, J
    Verstovsek, S
    Bueso-Ramos, C
    Shan, J
    Pierce, S
    Garcia-Manero, G
    Keating, M
    Kantarjian, H
    CANCER, 2005, 104 (03) : 547 - 554
  • [2] Acyclovir bioavailability in patients with acute myelogenous leukemia treated with daunorubicin and cytarabine
    Sitar, Daniel S.
    Aoki, Fred Y.
    Bow, Eric J.
    JOURNAL OF CLINICAL PHARMACOLOGY, 2008, 48 (08): : 995 - 998
  • [3] A MULTICENTER STUDY ON INTENSIVE INDUCTION AND CONSOLIDATION THERAPY IN ACUTE MYELOGENOUS LEUKEMIA
    KURRLE, E
    EHNINGER, G
    FREUND, M
    HEIL, G
    HOELZER, D
    LINK, H
    MITROU, PS
    OHL, S
    QUEISSER, W
    SCHLIMOK, G
    WANDT, H
    BLUT, 1988, 56 (05): : 233 - 236
  • [4] RESPONSE TO SALVAGE THERAPY AND SURVIVAL AFTER RELAPSE IN ACUTE MYELOGENOUS LEUKEMIA
    KEATING, MJ
    KANTARJIAN, H
    SMITH, TL
    ESTEY, E
    WALTERS, R
    ANDERSSON, B
    BERAN, M
    MCCREDIE, KB
    FREIREICH, EJ
    JOURNAL OF CLINICAL ONCOLOGY, 1989, 7 (08) : 1071 - 1080
  • [5] SUCCESSFUL RE-INDUCTION THERAPY FOR ACUTE MYELOGENOUS LEUKEMIA WITH CYTOSINE-ARABINOSIDE AND DAUNORUBICIN
    STEIN, RS
    FLEXNER, JM
    CANCER TREATMENT REPORTS, 1979, 63 (11-1): : 2123 - 2124
  • [6] CYTARABIN AND DAUNORUBICIN OR IDARUBICIN IN INDUCTION THERAPY OF ACUTE MYELOID LEUKEMIA PATIENTS
    Eivazi-Ziaei, Jamal
    Kermani, Iraj Asvadi
    Nikanfar, Alireza
    Maljaie, Hadi
    Mahmoudpour, Ali
    Dolatkhah, Roya
    Golchin, Mehri
    Vaez, Jalil
    PAKISTAN JOURNAL OF MEDICAL SCIENCES, 2009, 25 (05) : 829 - 832
  • [7] Mitoxantrone and prolonged infusion gemcitabine as salvage therapy in patients with acute myelogenous leukemia
    Apostolidou, E
    Estey, E
    Cortes, J
    Garcia-Manero, G
    Faderl, S
    Thomas, D
    Tsimberidou, A
    Kantarjian, H
    Giles, FJ
    LEUKEMIA RESEARCH, 2003, 27 (04) : 301 - 304
  • [8] HIGH-DOSE CYTARABINE AND DAUNORUBICIN INDUCTION AND POSTREMISSION CHEMOTHERAPY FOR THE TREATMENT OF ACUTE MYELOGENOUS LEUKEMIA IN ADULTS
    PHILLIPS, GL
    REECE, DE
    SHEPHERD, JD
    BARNETT, MJ
    BROWN, RA
    FREILAHR, DA
    KLINGEMANN, HG
    BOLWELL, BJ
    SPINELLI, JJ
    HERZIG, RH
    HERZIG, GP
    BLOOD, 1991, 77 (07) : 1429 - 1435
  • [9] PROGNOSIS OF PATIENTS WITH ACUTE MYELOGENOUS LEUKEMIA PRECEDED BY A PRELEUKEMIA SYNDROME COMPARED TO PATIENTS WITH DENOVO ACUTE MYELOGENOUS LEUKEMIA WHEN TREATED WITH INTENSIVE CHEMOTHERAPY
    GAJEWSKI, JL
    HO, WG
    HIRJI, KF
    NIMER, SD
    GALE, RP
    CHAMPLIN, RE
    EXPERIMENTAL HEMATOLOGY, 1988, 16 (06) : 476 - 476
  • [10] INTENSIVE CHEMOTHERAPY IS THE TREATMENT OF CHOICE FOR ELDERLY PATIENTS WITH ACUTE MYELOGENOUS LEUKEMIA
    FOON, KA
    ZIGHELBOIM, J
    YALE, C
    GALE, RP
    BLOOD, 1981, 58 (03) : 467 - 470
12345